ESMO 2020: Melanoma highlights through an Australian lens

Skin cancers

16 Oct 2020

Join the limbic and a panel of experts in a case-study based discussion of the breakthrough melanoma trials unveiled at the ESMO 2020 Virtual Congress and what they mean for clinical practice in Australia.

Viewers will have the opportunity to ask the panel questions during the live event.  Alternatively, send your question in advance.

Thursday 22nd October | 7:30pm tp 8:30pm AEDT



Hosted by:

Professor Georgina Long AO. Co-Medical Director of Melanoma Institute Australia (MIA); Chair, Melanoma Medical Oncology and Translational Research, MIA and Royal North Shore Hospital, The University of Sydney.

With special guests:

Professor Grant McArthur. Executive Director, Victorian Comprehensive Cancer Centre; Consultant Medical Oncologist, Peter MacCallum Cancer Centre; Head, Molecular Oncology Laboratory and Cancer Therapeutics Program, Peter MacCallum Cancer Centre; Lorenzo Galli Chair of Melanoma and Skin Cancers, University of Melbourne

Doctor Thomas Pennington. VMO General Surgeon and Surgical Oncologist, Royal Prince Alfred Hospital, Northern Beaches Hospital, Mater Hospital, Sydney. Affiliated with Melanoma Institute Australia.

Professor Angela Hong. Radiation oncologist at Melanoma Institute Australia, Chris O’Brien Lifehouse and Mater Hospital, North Sydney.

Doctor Brinda Shivalingam. Director of Neurosurgery, The Chris O’Brien Lifehouse; Consultant Neurosurgeon, Royal Prince Alfred Hospital and The Mater Hospital North Sydney.

This webinar is an independent initiative of the limbic in collaboration with Melanoma Institute Australia (MIA).

Thank you to Bristol Myers Squibb Pty Ltd for providing the financial support that made it possible.

Already a member?

Login to keep reading.

Email me a login link